Novel Direct Factor IIa and Xa Inhibitors: Mechanisms of Action and Preclinical Studies

E-ISSN： 2212-3938|7|3|149-165

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.7, Iss.3, 2012-01, pp. : 149-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacology of Direct and Indirect Factor Xa Inhibitors

By Rupprecht Hans-Juergen Blank Ralf

Drugs, Vol. 70, Iss. 16, 2010-11 ,pp. : 2153-2170

Adis International

Access to resources Recommend Favorite

Novel factor Xa inhibitors: a patent review

By de Candia Modesto Lopopolo Gianfranco Altomare Cosimo

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 11, 2009-11 ,pp. : 1535-1580

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Hot Topic: The New Kids on the Block: Oral Direct IIa and Xa Inhibitors Enter the Proscenium of Anticoagulation Treatment)

Current Clinical Pharmacology, Vol. 7, Iss. 3, 2012-08 ,pp. : 147-148

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

By Eriksson Bengt I.

Clinical Pharmacokinetics, Vol. 48, Iss. 1, 2009-01 ,pp. : 1-22

Adis International

Access to resources Recommend Favorite

Recent advances in clinical trials of the direct and indirect selective Factor Xa inhibitors

By Porcari A.R. Chi L. Leadley R.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1595-1600

Informa Healthcare

Access to resources Recommend Favorite